AU3091597A - Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca) - Google Patents

Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca)

Info

Publication number
AU3091597A
AU3091597A AU30915/97A AU3091597A AU3091597A AU 3091597 A AU3091597 A AU 3091597A AU 30915/97 A AU30915/97 A AU 30915/97A AU 3091597 A AU3091597 A AU 3091597A AU 3091597 A AU3091597 A AU 3091597A
Authority
AU
Australia
Prior art keywords
prevention
treatment
fudca
colorectal cancer
acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU30915/97A
Other languages
English (en)
Inventor
Leonhard Robert Capuano
Joyce Corey Gibson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis AG filed Critical Novartis AG
Publication of AU3091597A publication Critical patent/AU3091597A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
AU30915/97A 1996-05-23 1997-05-22 Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca) Abandoned AU3091597A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US1820296P 1996-05-23 1996-05-23
US60018202 1996-05-23
PCT/EP1997/002632 WO1997044043A1 (en) 1996-05-23 1997-05-22 Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca)

Publications (1)

Publication Number Publication Date
AU3091597A true AU3091597A (en) 1997-12-09

Family

ID=21786767

Family Applications (1)

Application Number Title Priority Date Filing Date
AU30915/97A Abandoned AU3091597A (en) 1996-05-23 1997-05-22 Prevention and treatment of colorectal cancer by 6-fluoroursodeoxycholic acid (6-fudca)

Country Status (10)

Country Link
US (1) US6426340B1 (cg-RX-API-DMAC10.html)
EP (1) EP0906106B1 (cg-RX-API-DMAC10.html)
JP (2) JP2000510858A (cg-RX-API-DMAC10.html)
AT (1) ATE394107T1 (cg-RX-API-DMAC10.html)
AU (1) AU3091597A (cg-RX-API-DMAC10.html)
CA (1) CA2253593C (cg-RX-API-DMAC10.html)
DE (1) DE69738667D1 (cg-RX-API-DMAC10.html)
ES (1) ES2306459T3 (cg-RX-API-DMAC10.html)
PT (1) PT906106E (cg-RX-API-DMAC10.html)
WO (1) WO1997044043A1 (cg-RX-API-DMAC10.html)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338457C (en) * 1998-07-24 2009-11-17 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
EP1105141B1 (de) * 1998-08-06 2003-11-05 Wolfgang Stremmel Phosphatidylcholin als arzneimittel mit schleimhautschützender wirkung
PT1218889E (pt) * 1999-09-28 2010-03-08 Panacea Biotec Ltd Composições de libertação controlada compreendendo nimesulida
US7053076B2 (en) 2001-08-29 2006-05-30 Xenoport, Inc. Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
EP1558763A4 (en) * 2002-11-01 2007-08-15 James Kaput IDENTIFICATION OF GENES ASSOCIATED WITH A DISEASE REGULATED BY A DIET
JP2010517941A (ja) * 2007-01-16 2010-05-27 ザ バーナム インスティテュート フォー メディカル リサーチ 結腸直腸癌の治療のための組成物および方法
EP2255813A1 (en) * 2009-05-29 2010-12-01 The Royal College of Surgeons in Ireland Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
MX366925B (es) 2010-11-04 2019-07-31 Albireo Ab Inhibidores de ibat para el tratamiento de enfermedades hepaticas.
CA2952406A1 (en) 2014-06-25 2015-12-30 Ea Pharma Co., Ltd. Solid formulation and method for preventing or reducing coloration thereof
JP6954927B2 (ja) 2016-02-09 2021-10-27 アルビレオ・アクチボラグ 経口コレスチラミン製剤及びその使用
CN108601744B (zh) 2016-02-09 2022-01-04 阿尔比里奥公司 口服考来烯胺制剂及其用途
CA3011595C (en) 2016-02-09 2024-01-02 Albireo Ab Cholestyramine pellets and methods for preparation thereof
CN111032019B (zh) 2017-08-09 2022-07-05 阿尔比里奥公司 考来烯胺颗粒、口服考来烯胺制剂及其用途
JP7391048B2 (ja) 2018-06-05 2023-12-04 アルビレオ・アクチボラグ ベンゾチア(ジ)アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
KR20210024033A (ko) 2018-06-20 2021-03-04 알비레오 에이비 오데빅시바트의 약학 제제
GB201812382D0 (en) 2018-07-30 2018-09-12 Nzp Uk Ltd Compounds
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
SG11202108566VA (en) 2019-02-06 2021-09-29 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
CN113453753B (zh) 2019-02-06 2024-07-23 阿尔比里奥公司 苯并硫氮杂环庚三烯化合物及其用作胆汁酸调节剂的用途
CA3158195A1 (en) 2019-12-04 2021-06-10 Per-Goran Gillberg Benzothia(di)azepine compounds and their use as bile acid modulators
WO2021110885A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
CA3158181A1 (en) 2019-12-04 2021-06-10 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
CN114786772B (zh) 2019-12-04 2024-04-09 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途
JP7665621B2 (ja) 2019-12-04 2025-04-21 アルビレオ・アクチボラグ ベンゾチアゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
ES3002777T3 (en) 2020-08-03 2025-03-07 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
AU2021379076A1 (en) 2020-11-12 2023-06-08 Albireo Ab Odevixibat for treating progressive familial intrahepatic cholestasis (pfic)
BR112023010799A2 (pt) 2020-12-04 2023-10-03 Albireo Ab Compostos de benzotia(di)azepina e seus usos como moduladores de ácidos biliares
CN117412955A (zh) 2021-06-03 2024-01-16 阿尔比里奥公司 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8825526D0 (en) * 1988-11-01 1988-12-07 Enzymatix Ltd Diagnosis
US5175320A (en) * 1989-04-17 1992-12-29 Giuliani S.P.A. Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
US5843929A (en) 1996-03-22 1998-12-01 Mayo Foundation For Medical Education And Research Chemoprevention of metachronous adenomatous colorectal polyps

Also Published As

Publication number Publication date
CA2253593A1 (en) 1997-11-27
PT906106E (pt) 2008-08-07
ES2306459T3 (es) 2008-11-01
WO1997044043A1 (en) 1997-11-27
US6426340B1 (en) 2002-07-30
ATE394107T1 (de) 2008-05-15
EP0906106B1 (en) 2008-05-07
DE69738667D1 (de) 2008-06-19
CA2253593C (en) 2008-07-08
EP0906106A1 (en) 1999-04-07
JP2000510858A (ja) 2000-08-22
JP2010059175A (ja) 2010-03-18

Similar Documents

Publication Publication Date Title
PT906106E (pt) Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca)
CA2350538A1 (en) Pyrazolopyrimidinone derivatives for the treatment of impotence
PL325825A1 (en) Microemulsion for use as a carrier for administering active compounds
CA2370030A1 (en) Sodium channel blocker compositions and the use thereof
WO1998051294A3 (en) Method and composition for treating cancers
HRP20020170A2 (en) Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events
WO2000016762A3 (en) Method for reducing nicotine dependency
CA2455774A1 (en) Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain
AU7239996A (en) Inhibition of tumor necrosis factor alpha
WO2001030802A3 (en) Therapeutic treatments comprising administration of certain steroids for blood cell deficiencies
WO2001052796A3 (en) Methods of using a beverage composition for treating dental erosion
AU7500794A (en) Novel use of dexmedetomidine
MY121623A (en) Methods of preventing breast cancer.
CA2326528A1 (en) Cholesterol sulfate compositions for artificial skin tanning
WO2001030331A3 (en) Therapeutic compositions including protein kinase c inhibitors
CA2116829A1 (en) Use of a pregnane derivative
WO2001080813A3 (en) Methods for preventing and treating alopecia induced by chemotherapy or radiotherapy
CA2289017A1 (en) The use of a nitroxide or a prodrug thereof in the prophylactic and therapeutic treatment of cancer
AU1767297A (en) Benzo(C)quinolizine derivatives, their preparation and use as 5alpha-reductases inhibitors
CA2098593A1 (en) Treatment method for cancer
AU6846300A (en) Use of cyamemazine for cold turkey benzodiazepine treatment
AU2002310920A1 (en) Pharmaceutical compositions comprising ascomycin
WO2001037784A3 (en) Method for preventing irinotecan induced diarrhea
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance
MX9604692A (es) Derivados de quinoxalina para el tratamiento de tinnitus.